BioBreakthroughs

Join us on the latest episode! Our Guest: Cary Claiborne, CEO of Adial Pharmaceuticals.

What you'll get out of this episode:
  • Meet Cary Claiborne: Discover the visionary CEO behind Adial Pharmaceuticals.
  • Understanding AD04: Dive into the science of this promising new treatment for alcohol use disorder.
  • The Impact of Alcohol Use Disorder: A closer look at the challenges and the need for better treatments.
  • A Glimpse into the Future: Explore how AD04 could revolutionize addiction treatment beyond alcohol use disorder.
  • Adial's Mission and Vision: Hear directly from Claiborne about the company's path forward and commitment to innovation.

To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/cary-claiborne-sr-84a2217/
Company LinkedIn: https://www.linkedin.com/company/adialpharma/
Website: https://www.adial.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

What is BioBreakthroughs?

Welcome to BioBreakthroughs, the podcast that delves deep into the world of biotech and pharmaceuticals to bring you the latest and most exciting advancements in the field. Join us as we explore groundbreaking discoveries, cutting-edge research, and game-changing innovations that are shaping the future of healthcare. Produced by Slice of Healthcare.